Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)
Clinical trial NCT02615002 · COMPLETED
Trial details
- NCT number
- NCT02615002
- Sponsor
- Neurim Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2019-06-01
- Enrollment
- 371
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.